18 research outputs found

    Consumo de inflorescencia de maguey Agave sp. (Aspargales: Aspargaceae) por la ardilla de Peters Parasciurus oculatus (Rodentia: Sciuridae) en la Reserva de la Biosfera Sierra Gorda de Guanajuato, México

    Get PDF
    Approximately 87.5% of flowering plant species are pollinated by animals, however, the magnitude of the impact on plant pollination by rodents, a group to which squirrels belong, has been underestimated due to the lack of information. For the first time, we documented the consumption of inflorescences, nectar or pollen of maguey (Agave sp.) By the Peters squirrel (Parasciurus oculatus). It is necessary to continue monitoring the pollinators of the magueys, in order to determine the role that squirrels play in the pollination or predation processes of these plants.Aproximadamente el 87,5 % de las especies de plantas con flores son polinizadas por animales, sin embargo, la magnitud del impacto en la polinización de plantas por parte de los roedores, grupo al que pertenecen las ardillas, ha sido subestimada por la falta de información. Documentamos por primera ocasión consumo de las inflorescencias, néctar o polen de maguey (Agave sp.) por la ardilla de Peters (Parasciurus oculatus). Es necesario continuar el monitoreo de los polinizadores de los magueyes, para determinar el papel que juegan las ardillas en los procesos de polinización o depredación de estas plantas

    Role of age and comorbidities in mortality of patients with infective endocarditis

    Get PDF
    [Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

    Experimental study of bluetooth, ZigBee and IEEE 802.15.4 technologies on board high-speed trains

    No full text
    This paper studies the feasibility of using low-power wireless technologies such as Bluetooth, IEEE 802.15.4 and ZigBee in high-speed railway scenarios that involve bidirectional ground-to-train communication. The presented results have been obtained through experimental tests conducted at the Madrid- Barcelona high-speed rail line. A multiplatform communication system has been installed in a high-speed train, circulating at velocities up to 300 km/h, whereas autonomous devices have been disseminated along of the railway path to communicate with the onboard devices. The conclusions drawn from this work will be used as guidelines for the future implementation of autonomous communication platforms for high-speed rail connectivity.Peer Reviewe

    Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children

    No full text
    Introduction. Extrahepatic portal vein obstruction is an important cause of portal hypertension among children. The etiology is heterogeneous and there are few evidences related to the optimal treatment. Aim and methods. To establish guidelines for the diagnosis and treatment of EHPVO in children, a group of gastroenterologists and pediatric surgery experts reviewed and analyzed data reported in the literature and issued evidence-based recommendations.Results. Pediatric EHPVO is idiopathic in most of the cases. Digestive hemorrhage and/or hypersplenism are the main symptoms. Doppler ultrasound is a non-invasive technique with a high degree of accuracy for the diagnosis. Morbidity is related to variceal bleeding, recurrent thrombosis, portal biliopathy and hypersplenism. Endoscopic therapy is effective in controlling acute variceal hemorrhage and it seems that vasoactive drug therapy can be helpful. For primary prophylaxis of variceal bleeding, there are insufficient data for the use of beta blockers or endoscopic therapy. For secondary prophylaxis, sclerotherapy or variceal band ligation is effective; there is scare evidence to recommend beta-blockers. Surgery shunt is indicated in children with variceal bleeding who fail endoscopic therapy and for symptomatic hypersplenism; spleno-renal or meso-ilio-cava shunting is the alternative when Mesorex bypass is not feasible due to anatomic problems or in centers with no experience.Conclusions. Prospective control studies are required for a better knowledge of the natural history of EHPVO, etiology identification including prothrombotic states, efficacy of beta-blockers and comparison with endoscopic therapy on primary and secondary prophylaxis
    corecore